PH27557A - Hexa-cyclic compound - Google Patents
Hexa-cyclic compoundInfo
- Publication number
- PH27557A PH27557A PH37104A PH37104A PH27557A PH 27557 A PH27557 A PH 27557A PH 37104 A PH37104 A PH 37104A PH 37104 A PH37104 A PH 37104A PH 27557 A PH27557 A PH 27557A
- Authority
- PH
- Philippines
- Prior art keywords
- compound
- hexa
- cyclic compound
- antitumour
- camptothecin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed systems contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D515/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D515/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains four or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Luminescent Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Lubricants (AREA)
- Fats And Perfumes (AREA)
- Liquid Crystal Substances (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP15699087 | 1987-06-24 | ||
JP550388 | 1988-01-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
PH27557A true PH27557A (en) | 1993-08-18 |
Family
ID=26339454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH37104A PH27557A (en) | 1987-06-24 | 1988-07-22 | Hexa-cyclic compound |
Country Status (13)
Country | Link |
---|---|
US (2) | US4939255A (fr) |
EP (1) | EP0296597B1 (fr) |
KR (1) | KR960002853B1 (fr) |
AT (1) | ATE111913T1 (fr) |
AU (1) | AU610189B2 (fr) |
CA (1) | CA1304370C (fr) |
DE (1) | DE3851577T2 (fr) |
DK (1) | DK344488A (fr) |
ES (1) | ES2064329T3 (fr) |
FI (1) | FI91872C (fr) |
IE (1) | IE61281B1 (fr) |
NO (1) | NO167738C (fr) |
PH (1) | PH27557A (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US5552154A (en) * | 1989-11-06 | 1996-09-03 | The Stehlin Foundation For Cancer Research | Method for treating cancer with water-insoluble s-camptothecin of the closed lactone ring form and derivatives thereof |
US5658920A (en) * | 1991-01-16 | 1997-08-19 | Daiichi Pharmaceutical Co., Ltd. | Substituted 1H,12H-benz-[DE]pyrano[3',4':6,7] indolizino[1,2-B]quinoline-10,13(9H,15H)-dione compound |
JP3008226B2 (ja) * | 1991-01-16 | 2000-02-14 | 第一製薬株式会社 | 六環性化合物 |
US6407115B1 (en) * | 1991-01-16 | 2002-06-18 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic compound |
US6080751A (en) * | 1992-01-14 | 2000-06-27 | The Stehlin Foundation For Cancer Research | Method for treating pancreatic cancer in humans with water-insoluble S-camptothecin of the closed lactone ring form and derivatives thereof |
US5391745A (en) * | 1992-07-23 | 1995-02-21 | Sloan-Kettering Institute For Cancer Research | Methods of preparation of camptothecin analogs |
US5446047A (en) * | 1992-07-23 | 1995-08-29 | Sloan-Kettering Institute For Cancer Research | Camptothecin analogues |
US6504029B1 (en) | 1995-04-10 | 2003-01-07 | Daiichi Pharmaceutical Co., Ltd. | Condensed-hexacyclic compounds and a process therefor |
US5663177A (en) * | 1995-05-31 | 1997-09-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
US5670500A (en) * | 1995-05-31 | 1997-09-23 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
US5942386A (en) * | 1995-06-07 | 1999-08-24 | Thomas Jefferson University | Anti-fungal agents and methods of identifying and using the same |
SG50747A1 (en) * | 1995-08-02 | 1998-07-20 | Tanabe Seiyaku Co | Comptothecin derivatives |
SG88737A1 (en) * | 1996-10-30 | 2002-05-21 | Tanabe Seiyaku Co | S type 2-substituted hydroxy-2-indolidinylbutyric ester compounds and process for preparation thereof |
KR19980076076A (ko) * | 1997-04-04 | 1998-11-16 | 유현식 | 전선용 발포성 수지조성물 |
US6046209A (en) * | 1997-05-27 | 2000-04-04 | Smithkline Beecham Corporation | Water soluble camptothecin analogs |
IN189180B (fr) * | 1997-07-09 | 2003-01-04 | Chong Kun Dang Corp | |
JP4094710B2 (ja) | 1997-11-06 | 2008-06-04 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
CA2385528C (fr) | 1999-10-01 | 2013-12-10 | Immunogen, Inc. | Compositions et methodes de traitement du cancer utilisant des immunoconjugues et des agents chimiotherapeutiques |
FR2801309B1 (fr) * | 1999-11-18 | 2002-01-04 | Adir | Nouveaux composes analogues de la camptothecine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
MXPA04005185A (es) * | 2001-11-30 | 2004-08-11 | Chugai Pharmaceutical Co Ltd | Compuestos hexaciclicos. |
US7563810B2 (en) | 2002-11-06 | 2009-07-21 | Celgene Corporation | Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases |
US8034831B2 (en) | 2002-11-06 | 2011-10-11 | Celgene Corporation | Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies |
WO2004073601A2 (fr) * | 2003-02-21 | 2004-09-02 | Chugai Seiyaku Kabushiki Kaisha | Nouveau procede de preparation de composes hexacycliques |
MXPA06011679A (es) | 2004-04-09 | 2007-01-23 | Chugai Pharmaceutical Co Ltd | Novedosos profarmacos solubles en agua. |
TW200744603A (en) | 2005-08-22 | 2007-12-16 | Chugai Pharmaceutical Co Ltd | Novel anticancer concomitant drug |
CN102060713A (zh) * | 2010-12-09 | 2011-05-18 | 中华人民共和国嘉兴出入境检验检疫局 | 用于检测偶氮类染料的芳香胺半抗原及其制备方法 |
US20220211863A1 (en) | 2019-03-29 | 2022-07-07 | Medimmune Limited | Compounds and conjugates thereof |
CN114980934A (zh) | 2020-01-22 | 2022-08-30 | 免疫医疗有限公司 | 化合物及其缀合物 |
TW202140076A (zh) * | 2020-01-22 | 2021-11-01 | 英商梅迪繆思有限公司 | 化合物及其軛合物 |
US11806405B1 (en) | 2021-07-19 | 2023-11-07 | Zeno Management, Inc. | Immunoconjugates and methods |
WO2023180484A1 (fr) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Conjugués d'anticorps pour le ciblage de tumeurs exprimant ptk7 |
WO2023180485A1 (fr) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Anticorps-conjugués pour le ciblage de tumeurs exprimant trop-2 |
WO2023180490A1 (fr) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Conjugués d'anticorps pour le ciblage de tumeurs exprimant nectine-4 |
WO2023180489A1 (fr) | 2022-03-23 | 2023-09-28 | Synaffix B.V. | Anticorps-conjugués pour le ciblage de tumeurs exprimant un antigène carcinoembryonnaire |
WO2024140933A1 (fr) * | 2022-12-30 | 2024-07-04 | 长春金赛药业有限责任公司 | Dérivé de camptothécine, composition pharmaceutique et procédé de préparation et utilisation associés |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US32518A (en) * | 1861-06-11 | Improvement in city railroads | ||
JPS51288A (ja) * | 1974-06-18 | 1976-01-05 | Tamura Seisakusho Kk | Hanshakyoshinhoshasochi |
US4399282A (en) | 1979-07-10 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives |
US4399276A (en) * | 1981-01-09 | 1983-08-16 | Kabushiki Kaisha Yakult Honsha | 7-Substituted camptothecin derivatives |
US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS5839685A (ja) * | 1981-09-04 | 1983-03-08 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体及びその製造法 |
JPS58154582A (ja) * | 1982-03-10 | 1983-09-14 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体およびその製造法 |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
EP0220601B1 (fr) * | 1985-10-21 | 1991-12-11 | Daiichi Seiyaku Co., Ltd. | Dérivés de la pyranoindolizine et procédé de préparation |
US4939255A (en) * | 1987-06-24 | 1990-07-03 | Daiichi Pharmaceutical Co., Ltd. | Hexa-cyclic camptothecin derivatives |
US5004758A (en) * | 1987-12-01 | 1991-04-02 | Smithkline Beecham Corporation | Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells |
JPH0615547B2 (ja) * | 1988-01-20 | 1994-03-02 | 株式会社ヤクルト本社 | 新規なカンプトテシン誘導体 |
-
1988
- 1988-06-16 US US07/207,718 patent/US4939255A/en not_active Expired - Fee Related
- 1988-06-20 IE IE186088A patent/IE61281B1/en not_active IP Right Cessation
- 1988-06-21 CA CA000569969A patent/CA1304370C/fr not_active Expired - Lifetime
- 1988-06-23 ES ES88110044T patent/ES2064329T3/es not_active Expired - Lifetime
- 1988-06-23 NO NO882785A patent/NO167738C/no unknown
- 1988-06-23 DE DE3851577T patent/DE3851577T2/de not_active Expired - Fee Related
- 1988-06-23 EP EP88110044A patent/EP0296597B1/fr not_active Expired - Lifetime
- 1988-06-23 DK DK344488A patent/DK344488A/da not_active Application Discontinuation
- 1988-06-23 AT AT88110044T patent/ATE111913T1/de not_active IP Right Cessation
- 1988-06-23 FI FI883050A patent/FI91872C/fi not_active IP Right Cessation
- 1988-06-24 AU AU18349/88A patent/AU610189B2/en not_active Ceased
- 1988-06-24 KR KR1019880007643A patent/KR960002853B1/ko not_active IP Right Cessation
- 1988-07-22 PH PH37104A patent/PH27557A/en unknown
-
1989
- 1989-12-27 US US07/457,921 patent/US5061795A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
NO882785L (no) | 1988-12-27 |
DK344488D0 (da) | 1988-06-23 |
CA1304370C (fr) | 1992-06-30 |
KR890000489A (ko) | 1989-03-15 |
DE3851577T2 (de) | 1995-04-27 |
FI883050A (fi) | 1988-12-25 |
DE3851577D1 (de) | 1994-10-27 |
NO167738C (no) | 1991-12-04 |
DK344488A (da) | 1989-02-24 |
NO167738B (no) | 1991-08-26 |
FI91872C (fi) | 1994-08-25 |
FI883050A0 (fi) | 1988-06-23 |
US4939255A (en) | 1990-07-03 |
EP0296597B1 (fr) | 1994-09-21 |
IE61281B1 (en) | 1994-10-19 |
FI91872B (fi) | 1994-05-13 |
ATE111913T1 (de) | 1994-10-15 |
US5061795A (en) | 1991-10-29 |
AU1834988A (en) | 1989-01-05 |
ES2064329T3 (es) | 1995-02-01 |
EP0296597A3 (fr) | 1991-07-31 |
NO882785D0 (no) | 1988-06-23 |
EP0296597A2 (fr) | 1988-12-28 |
AU610189B2 (en) | 1991-05-16 |
IE881860L (en) | 1988-12-24 |
KR960002853B1 (ko) | 1996-02-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH27557A (en) | Hexa-cyclic compound | |
GR3020395T3 (en) | Hexa-cyclic compound | |
YU69289A (en) | Substituted flavonoidic compounds, their salts and process for producing thereof | |
AU577928B2 (en) | Labd-14-en-11-one derivatives | |
CA2030346A1 (fr) | Traitement de troubles cardiaques a l'aide de composes de 15-ceto-prostaglandines | |
HUT46214A (en) | Process for producing medical preparation suitable for treatment of peptic ulcer | |
IE883116L (en) | Preparation of antiviral and antitumour pharmaceutical and¹veterinary composition | |
GR890300022T1 (en) | Process for the preparation of 5-hydroxydipraphenone and its salts with acids | |
PT75881A (en) | Process for preparing 3-methyl-3-(4-acetylaminophenoxy)-2,4-dioxa-benzocyclohexen-1-one having analgesic antiinflammatory and antipiretic activity and of pharmaceutical compositions containing the same | |
EP0307226B1 (en) | Process for the preparation of a macrolide compound |